1,460 reports of this reaction
2.5% of all CINACALCET HYDROCHLORIDE reports
#10 most reported adverse reaction
ADVERSE DRUG REACTION is the #10 most commonly reported adverse reaction for CINACALCET HYDROCHLORIDE, manufactured by Amgen Inc. There are 1,460 FDA adverse event reports linking CINACALCET HYDROCHLORIDE to ADVERSE DRUG REACTION. This represents approximately 2.5% of all 57,261 adverse event reports for this drug.
Patients taking CINACALCET HYDROCHLORIDE who experience adverse drug reaction should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ADVERSE DRUG REACTION is a less commonly reported adverse event for CINACALCET HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to adverse drug reaction, the following adverse reactions have been reported for CINACALCET HYDROCHLORIDE:
The following drugs have also been linked to adverse drug reaction in FDA adverse event reports:
ADVERSE DRUG REACTION has been reported as an adverse event in 1,460 FDA reports for CINACALCET HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ADVERSE DRUG REACTION accounts for approximately 2.5% of all adverse event reports for CINACALCET HYDROCHLORIDE, making it a notable side effect.
If you experience adverse drug reaction while taking CINACALCET HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.